MoonLake Immunotherapeutics · NASDAQ:MLTX

MoonLake Immunotherapeutics financial statements

MoonLake Immunotherapeutics's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue0000
Cost of revenue2.62M1.38M13.2K12.4K4.97K
Gross profit-2.62M-1.38M-13.2K-12.4K-4.97K
Research and development202.9M112.8M31.8M42.0M35.5M
Selling, general and administrative42.0M30.3M22.3M23.0M4.57M
Operating income-244.8M-143.1M-54.1M-65.1M-4.57M-105.8K
Depreciation and amortization2.62M1.39M370.0K164.8K4.97K206.3K
EBITDA-242.2M-141.7M-53.8M-64.9M-4.57M100.5K
Interest expense7.25M00591.7K0
Income before tax-229.7M-121.0M-44.0M-64.5M-4.54M-90.8K
Income tax611.0K282.0K94.0K36.4K5.71K-206.3K
Net income-227.3M-118.9M-36.0M-50.0M-4.54M-90.8K
Earnings per share, basic-3.53-1.89-0.73-1.70-0.31-0.01
Earnings per share, diluted-3.53-1.89-0.73-1.70-0.31

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents334.5M180.4M451.2M39.5M8.04M1.34M
Short-term investments59.5M267.6M59.8M32.6M0
Receivables4.87M2.84M1.06M217.1K148.8K
Inventory1.32M
Current assets421.7M474.3M514.2M76.5M9.64M1.62M
Property, plant and equipment577.0K722.0K320.9K49.4K45.7K
Total assets424.4M477.9M526.5M76.8M9.68M116.6M
Accounts payable28.4M8.68M1.46M47.5K1.23M
Current liabilities45.5M22.5M9.97M7.67M21.1M125.2K
Long-term debt74.1M
Total debt74.1M03.70M282.6K15.0M58.1K
Total liabilities120.0M24.5M13.0M8.08M21.3M4.15M
Shareholders' equity304.5M446.8M495.7M48.9M-11.6M112.5M
Shares outstanding85.1M62.9M49.1M29.4M36.9M14.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-196.0M-116.6M-42.8M-55.9M-611.1K-316.7K
Capital spending-35.0K-520.0K-284.0K-16.0K-50.7K0
Free cash flow-196.0M-117.1M-43.1M-55.9M-35.2M-316.7K
Cash from investing203.0M-205.6M-25.2M-32.3M-50.7K-115.0M
Cash from financing146.0M51.3M479.7M119.7M-58.1K116.7M
Dividends paid-51.9K
Share buybacks-5000-6.20K
Change in cash154.1M-270.7M411.7M31.5M-669.1K1.34M